| Apalutamide for metastatic, castration-sensitive prostate cancer KN Chi, N Agarwal, A Bjartell, BH Chung, AJ Pereira de Santana Gomes, ... New England Journal of Medicine 381 (1), 13-24, 2019 | 1254 | 2019 |
| Active surveillance for low-risk prostate cancer worldwide: the PRIAS study M Bul, X Zhu, R Valdagni, T Pickles, Y Kakehi, A Rannikko, A Bjartell, ... European urology 63 (4), 597-603, 2013 | 624 | 2013 |
| MicroRNA in prostate, bladder, and kidney cancer: a systematic review JWF Catto, A Alcaraz, AS Bjartell, RDV White, CP Evans, S Fussel, ... European urology 59 (5), 671-681, 2011 | 560 | 2011 |
| Urinary incontinence and erectile dysfunction after robotic versus open radical prostatectomy: a prospective, controlled, nonrandomised trial E Haglind, S Carlsson, J Stranne, A Wallerstedt, U Wilderäng, ... European urology 68 (2), 216-225, 2015 | 512 | 2015 |
| ETS gene fusions in prostate cancer: from discovery to daily clinical practice SA Tomlins, A Bjartell, AM Chinnaiyan, G Jenster, RK Nam, MA Rubin, ... European urology 56 (2), 275-286, 2009 | 472 | 2009 |
| Enzalutamide in men with chemotherapy-naive metastatic castration-resistant prostate cancer: extended analysis of the phase 3 PREVAIL study TM Beer, AJ Armstrong, D Rathkopf, Y Loriot, CN Sternberg, CS Higano, ... European urology 71 (2), 151-154, 2017 | 449 | 2017 |
| The role of SPINK1 in ETS rearrangement-negative prostate cancers SA Tomlins, DR Rhodes, J Yu, S Varambally, R Mehra, S Perner, ... Cancer cell 13 (6), 519-528, 2008 | 399 | 2008 |
| Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019 S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ... European urology 77 (4), 508-547, 2020 | 367 | 2020 |
| The contemporary concept of significant versus insignificant prostate cancer G Ploussard, JI Epstein, R Montironi, PR Carroll, M Wirth, MO Grimm, ... European urology 60 (2), 291-303, 2011 | 366 | 2011 |
| Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study AJ Vickers, D Ulmert, DD Sjoberg, CJ Bennette, T Björk, A Gerdtsson, ... Bmj 346, 2013 | 357 | 2013 |
| Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth B Wegiel, D Gallo, E Csizmadia, C Harris, J Belcher, GM Vercellotti, ... Cancer research 73 (23), 7009-7021, 2013 | 346 | 2013 |
| Apalutamide in patients with metastatic castration-sensitive prostate cancer: final survival analysis of the randomized, double-blind, phase III TITAN study KN Chi, S Chowdhury, A Bjartell, BH Chung, ... Journal of Clinical Oncology 39 (20), 2294-2303, 2021 | 331 | 2021 |
| Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells P Östling, SK Leivonen, A Aakula, P Kohonen, R Mäkelä, Z Hagman, ... Cancer research 71 (5), 1956-1967, 2011 | 319 | 2011 |
| Advances in magnetic resonance imaging: how they are changing the management of prostate cancer A Sciarra, J Barentsz, A Bjartell, J Eastham, H Hricak, V Panebianco, ... European urology 59 (6), 962-977, 2011 | 316 | 2011 |
| The human cationic antimicrobial protein (hCAP-18) is expressed in the epithelium of human epididymis, is present in seminal plasma at high concentrations, and is attached to … J Malm, O Sørensen, T Persson, M Frohm-Nilsson, B Johansson, ... Infection and immunity 68 (7), 4297-4302, 2000 | 301 | 2000 |
| The mutational landscape of prostate cancer CE Barbieri, CH Bangma, A Bjartell, JWF Catto, Z Culig, H Grönberg, ... European urology 64 (4), 567-576, 2013 | 291 | 2013 |
| Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study AJ Vickers, AM Cronin, T Björk, J Manjer, PM Nilsson, A Dahlin, A Bjartell, ... Bmj 341, 2010 | 286 | 2010 |
| Positive surgical margins in radical prostatectomy: outlining the problem and its long-term consequences O Yossepowitch, A Bjartell, JA Eastham, M Graefen, BD Guillonneau, ... European urology 55 (1), 87-99, 2009 | 278 | 2009 |
| SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas K Magnusson, M De Wit, DJ Brennan, LB Johnson, SF McGee, ... The American journal of surgical pathology 35 (7), 937-948, 2011 | 271 | 2011 |
| Epigenetics in prostate cancer: biologic and clinical relevance C Jerónimo, PJ Bastian, A Bjartell, GM Carbone, JWF Catto, SJ Clark, ... European urology 60 (4), 753-766, 2011 | 257 | 2011 |
